Company: NIVFW
Filing Date: 2025-04-22
Form Type: 20-F
Source: 0001213900-25-033966
Chunk: 109

Company: NewGenIvf Group Ltd
Filing Date: 2025-04-22
Form: 20-F
Item: Item 10
Chunk 109
---
ITEM 10. ADDITIONAL INFORMATION

A. Share Capital

Not applicable.

B. Memorandum and Articles of Association

A copy of our amended and
restated memorandum and articles of association is filed as Exhibit 1.1 to this Report.

C. Material Contracts

Material Contracts Relating to our Operations

Other than contracts entered
into in the ordinary course of business and other than those described under “ Item 4. Information on the Company,” “ Item
7. Major Shareholders and Related Party Transactions” or described elsewhere in this annual report, the following contracts summarized
below are the material contracts that the Company has been a party to for the two years preceding the publication of this Annual Report.

JAK Securities Purchase
Agreement

On August 7, 2024, the Company
entered into a Securities Purchase Agreement (“ Securities Purchase Agreement”) with JAK OPPORTUNITIES VI LLC (“ JAK”),
pursuant to which, amongst other things: (i) the Company agreed to sell, at an initial closing, (a) a senior convertible note in the aggregate
original principal amount not exceeding $1,100,000, convertible into Class A Ordinary Shares pursuant to its terms, (b) a warrant to purchase
1,325,301 Class A Ordinary Shares, and (c) a warrant to purchase 180,722 Class A Ordinary Shares; and (ii) the Company may require JAK
(or JAK may require the Company, as applicable) to participate in the sale of (a) one or more additional convertible notes (which aggregate
original principal amount for all additional convertible notes shall not exceed $9,500,000) and (b) related Warrants. A copy of the Securities
Purchase Agreement is filed as Exhibit 4.25 to this Report.

On April 1, 2025, the Company
entered into a new Securities Purchase Agreement (“2025 Securities Purchase Agreement”) with JAK, pursuant to which, amongst
other things: (i) the Company agreed to sell, at an initial closing, a senior convertible note in the aggregate original principal amount
not exceeding $3,200,000, convertible into Class A Ordinary Shares pursuant to its terms; and (ii) the Company may require JAK (or JAK
may require the Company, as applicable) to participate in the sale of one or more additional convertible notes (which aggregate original
principal amount for all additional convertible notes shall not exceed $25,600,000). A copy of